DK0514413T3 - Immunologically active peptide or polypeptide of parvovirus B19 - Google Patents

Immunologically active peptide or polypeptide of parvovirus B19

Info

Publication number
DK0514413T3
DK0514413T3 DK91903270.6T DK91903270T DK0514413T3 DK 0514413 T3 DK0514413 T3 DK 0514413T3 DK 91903270 T DK91903270 T DK 91903270T DK 0514413 T3 DK0514413 T3 DK 0514413T3
Authority
DK
Denmark
Prior art keywords
gene
parvovirus
antigens
immunologically active
igg
Prior art date
Application number
DK91903270.6T
Other languages
Danish (da)
Inventor
Manfred Motz
Erwin Soutschek
Original Assignee
Mikrogen Molekularbiol Entw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikrogen Molekularbiol Entw filed Critical Mikrogen Molekularbiol Entw
Application granted granted Critical
Publication of DK0514413T3 publication Critical patent/DK0514413T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Immunologically active peptides or polypeptides with a partial amino acid sequence of the capside protein VP1 and VP2 of parvovirus B19 are obtained which provide an economical, sensitive and specific test to detect antibodies against the human parvovirus B19. Short peptide sequences are identified which when used as an antigen serve to identify anti-B19 IgG-positive sera. The production of these peptides by gene-technological means is revealed. Other gene-technologically produced antigens which form stably in large quantities in E. Coli and can subsequently be separated from them act as additional antigens for IgG confirmation. Finally a set of antigens facilitates testing for the detection of IgM antibodies against the virus. In addition, the gene-technologically produced components of the surface proteins are substances which may be used for prophylactic immunisation.
DK91903270.6T 1990-02-08 1991-02-08 Immunologically active peptide or polypeptide of parvovirus B19 DK0514413T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4003826A DE4003826C2 (en) 1990-02-08 1990-02-08 Peptides of the capsid proteins VP1 or VP2 of the parvovirus B19

Publications (1)

Publication Number Publication Date
DK0514413T3 true DK0514413T3 (en) 1994-06-06

Family

ID=6399718

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91903270.6T DK0514413T3 (en) 1990-02-08 1991-02-08 Immunologically active peptide or polypeptide of parvovirus B19

Country Status (9)

Country Link
EP (1) EP0514413B1 (en)
JP (2) JP3061196B2 (en)
AT (1) ATE105303T1 (en)
AU (1) AU650864B2 (en)
CA (1) CA2075366C (en)
DE (2) DE4003826C2 (en)
DK (1) DK0514413T3 (en)
ES (1) ES2052370T3 (en)
WO (1) WO1991012269A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3149116B2 (en) * 1992-10-28 2001-03-26 信越化学工業株式会社 Epitope-related peptide of human parvovirus
DE69415462T2 (en) * 1993-01-23 1999-07-15 Inmunologia Y Genetica Aplicada, S.A., Madrid SYNTHETIC PEPTIDES AND VACCINE AGAINST PARVOVIRUS
EP0725837B1 (en) 1993-10-28 2000-01-12 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Adeno-associated virus - its diagnostic use with early abortion
WO1996027799A1 (en) * 1995-03-08 1996-09-12 Klaus Hedman Method for the diagnosis of infections
JPH0910000A (en) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya Detection of human parvovirus and reagent therefor
FR2771751B1 (en) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris ERYTHROVIRUS AND ITS APPLICATIONS
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
KR100944674B1 (en) 2001-06-28 2010-03-04 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 Diagnostic assays for parvovirus b19
US7094541B2 (en) 2001-08-31 2006-08-22 Gen-Probe Incorporated Assay for detection of human parvovirus B19 nucleic acid
WO2007096199A2 (en) * 2006-02-22 2007-08-30 Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh Differential diagnostics and therapy of virally induced heart muscle disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7966987A (en) * 1986-09-08 1988-04-07 Applied Biotechnology, Inc. Empty viral capsid vaccines
DE3939470A1 (en) * 1989-11-29 1991-06-06 Biochrom Beteiligungs Gmbh & C Diagnosis and prevention of human parvovirus B19 infection - using synthetic penta- and higher peptide(s) and antibodies

Also Published As

Publication number Publication date
CA2075366C (en) 2003-02-18
EP0514413A1 (en) 1992-11-25
DE59101577D1 (en) 1994-06-09
JP3130024B2 (en) 2001-01-31
DE4003826C2 (en) 1995-11-23
EP0514413B1 (en) 1994-05-04
ATE105303T1 (en) 1994-05-15
ES2052370T3 (en) 1994-07-01
JP3061196B2 (en) 2000-07-10
CA2075366A1 (en) 1991-08-09
JP2000184889A (en) 2000-07-04
AU650864B2 (en) 1994-07-07
DE4003826A1 (en) 1991-08-14
WO1991012269A1 (en) 1991-08-22
AU7211591A (en) 1991-09-03
JPH05504143A (en) 1993-07-01

Similar Documents

Publication Publication Date Title
FI910720A (en) SYNTHETIC PEPTIDER SPECIFIC FOER DETEKTERING AV HCV ANTIKROPPAR, DIAGNOS AV HCV INFEKTION OCH PREVENTION AV INFEKTIONEN SOM VACCIN.
DK0514413T3 (en) Immunologically active peptide or polypeptide of parvovirus B19
DE69327587D1 (en) Conjugates of weakly immunogenic antigenic and synthetic peptide carriers and vaccines containing them
DK0522030T3 (en) Hepatitis B vaccine
ATE53219T1 (en) HTLV III POLYPEPTIDES.
ATE80310T1 (en) ANTIGENIC PROTEINS, VACCINES CONTAINING THE SAME, PROTECTIVE ANTIBODIES ON THE OTHER HAND FOR THE PREVENTION OF COCCIDIOSIS CAUSED BY EIMERIA TENELLA.
ATE382696T1 (en) IMMUNOREACTIVE ANTIGENS OF THE HEPATITIS E VIRUSE
Buchanan-Davidson et al. Immunochemistry of Synthetic Polypeptides and Polypeptidyl Proteins: III. Antigenicity of the Synthetic Polypeptides
ES2136653T3 (en) SYNTHESIS POLYPEPTIDES BELONGING TO HEPATITIS C VIRUS (HCV) AND MAINLY USABLE TO DETECT THIS LAST.
FI854839A (en) VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID.
ATE71534T1 (en) VACCINE.
Leroy Precipitating and complement-fixing antibodies to collagen with species and collagen subunit specificity
DE69017352D1 (en) Peptides related to HIV.
JPH03503416A (en) peptide
ATE134648T1 (en) ARTIFICIAL POLYPEPTIDES AND ANTIBODIES RELATED TO EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN
Esandi Isolation and characterization of antibodies from sera of humans infected with Echinococcus granulosus
RU92004487A (en) DNA, POLIPEPTID, VACCINE, VECTOR, MICROORGANISM, INSECTED CELL, REAGENT, METHODS OF TREATMENT AND PREVENTION, METHOD OF DETECTING ANTIGENES